The most resilient group remains big tech. Alphabet still holds its uptrend, Microsoft’s weakness is shallow, and Meta is firming. In healthcare, Eli Lilly and Novo Nordisk stay strong due to solid GLP1 demand. Among semiconductors, Nvidia, Broadcom, and TSMC show early buying interest, though not a confirmed reversal.
Weaker areas have likely not bottomed. Oracle still faces credit pressure, making further downside possible. Speculative AI names, crypto stocks, and Bitcoin remain fragile, with no clear support forming yet.
For bottom fishing, focus only on high quality leaders and avoid laggards. If cautious, wait for better market breadth and lower volatility. If scaling in, use small staggered entries into the strongest large caps until conditions stabilise.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- fizzik·2025-11-24Big tech still holding up better [666] Healthcare plays holding trendline. Semis need more volume confirmation. Avoid chasing weak names.LikeReport
- Phyllis Strachey·2025-11-24Staggered entries into NVDA/TSMC are smart amid yield jitters!LikeReport
- Jo Betsy·2025-11-24Big tech’s resilience + GLP-1 strength = market floor is near!LikeReport
